Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ligand Pharmaceuticals - 33 Year Stock Price History | LGND

Historical daily share price chart and data for Ligand Pharmaceuticals since 1992 adjusted for splits and dividends. The latest closing stock price for Ligand Pharmaceuticals as of July 01, 2025 is 112.56.
  • The all-time high Ligand Pharmaceuticals stock closing price was 171.24 on September 28, 2018.
  • The Ligand Pharmaceuticals 52-week high stock price is 129.90, which is 15.4% above the current share price.
  • The Ligand Pharmaceuticals 52-week low stock price is 81.74, which is 27.4% below the current share price.
  • The average Ligand Pharmaceuticals stock price for the last 52 weeks is 108.67.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Ligand Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 109.9552 108.4200 122.2300 96.6700 112.5600 5.05%
2024 92.0149 72.3100 129.9000 68.5300 107.1500 50.03%
2023 67.6952 66.0300 79.3300 49.5700 71.4200 6.92%
2022 63.2471 94.5477 94.5477 46.4878 66.8000 -30.67%
2021 86.7837 63.0505 134.6410 62.0836 96.3568 55.31%
2020 61.3582 65.3400 79.0518 39.5321 62.0399 -4.64%
2019 69.6699 85.4648 88.8771 53.8054 65.0593 -23.15%
2018 117.0843 86.4816 171.2350 80.0749 84.6538 -0.90%
2017 75.4381 63.9426 91.7280 62.6201 85.4211 34.76%
2016 67.9819 63.9239 86.4192 53.5184 63.3874 -6.28%
2015 54.0040 33.5184 69.7754 32.1522 67.6357 103.76%
2014 36.9259 32.1397 49.6444 26.4255 33.1940 1.16%
2013 23.1730 12.9258 36.1510 11.9526 32.8135 153.62%
2012 9.9529 7.4298 13.4311 7.1678 12.9382 74.72%
2011 7.1613 5.6082 9.9501 5.3961 7.4049 33.07%
2010 5.8453 7.4155 7.4155 4.7842 5.5646 -24.96%
2009 8.7186 9.2267 10.7644 5.6726 7.4155 -20.80%
2008 11.0055 16.6079 16.6079 4.3399 9.3633 -43.27%
2007 22.8008 27.9525 33.2816 13.3273 16.5054 -41.17%
2006 28.1130 29.4641 35.3569 20.3687 28.0550 -1.79%
2005 21.0533 28.6955 29.8484 12.1700 28.5673 -4.21%
2004 36.6444 38.2521 61.5415 20.1381 29.8228 -20.76%
2003 27.5471 14.0147 41.3010 9.5566 37.6372 173.56%
2002 29.5421 43.6837 51.2163 12.5799 13.7584 -70.00%
2001 30.8610 35.2288 48.6799 20.1125 45.8615 27.86%
2000 36.2779 35.5491 65.1733 25.2207 35.8693 8.74%
1999 25.0894 28.6634 35.7092 16.8137 32.9870 10.75%
1998 30.6537 32.6667 41.3138 14.7320 29.7844 -9.71%
1997 34.2790 39.3522 46.9184 23.3791 32.9870 -13.45%
1996 33.7549 26.5817 48.6799 26.2615 38.1112 38.37%
1995 20.1352 20.4968 28.1831 14.0915 27.5426 30.30%
1994 30.3309 30.7452 36.5099 16.0131 21.1373 -29.79%
1993 26.1919 31.3857 31.3857 22.4183 30.1046 11.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.193B $0.167B
Ligand, being a biotechnology company, focuses on developing/acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure. Ligand's Captisol formulation technology has allowed it to enter into several licensing deals and generate royalties. Captisol is a well validated chemically modified cyclodextrin that is designed to improve safety and solubility, stability, and bioavailability or lessen the volatility, irritation, smell or taste of drugs. Ligand has merged with CyDex. By this, it added an antibody-generating platform, OmniAb, to the company's portfolio. Its other technology platforms include antigen discovery platform & protein expression platform. All these technologies have created a strong platform for Ligand to seek new licenses and partnerships. Ligand has partnership agreements with leading healthcare companies like Novartis, Amgen, Merck, Pfizer, Celgene, Gilead & Lilly, etc. The company continues to buy smaller companies to increase its technology platforms.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $216.720B 16.18
Amgen (AMGN) United States $150.133B 13.45
Gilead Sciences (GILD) United States $137.914B 14.32
Vertex Pharmaceuticals (VRTX) United States $114.326B 0.00
Bristol Myers Squibb (BMY) United States $94.204B 6.31
GSK (GSK) United Kingdom $78.618B 9.41
CSL (CSLLY) Australia $76.699B 0.00
Regeneron Pharmaceuticals (REGN) United States $56.682B 13.76
Alnylam Pharmaceuticals (ALNY) United States $42.518B 0.00
Argenex SE (ARGX) Netherlands $33.657B 91.87
BioNTech SE (BNTX) Germany $25.595B 0.00
Royalty Pharma (RPRX) United States $20.258B 8.56
Insmed (INSM) United States $19.093B 0.00
Biogen (BIIB) United States $18.402B 7.94
Illumina (ILMN) United States $15.103B 28.65
Genmab (GNMSF) Denmark $13.948B 14.26
Genmab (GMAB) Denmark $13.248B 14.86
Incyte (INCY) United States $13.182B 100.15
Exelixis (EXEL) United States $12.020B 20.41
QIAGEN (QGEN) Netherlands $10.683B 20.79
Moderna (MRNA) United States $10.670B 0.00
Ascendis Pharma (ASND) Denmark $10.551B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.542B 17.12
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $10.024B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $8.426B 0.00
Blueprint Medicines (BPMC) United States $8.278B 0.00
Bio-Techne Corp (TECH) United States $8.066B 30.09
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.052B 0.00
Roivant Sciences (ROIV) United Kingdom $7.661B 0.00
Repligen (RGEN) United States $6.988B 78.23
Revolution Medicines (RVMD) United States $6.853B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Legend Biotech (LEGN) United States $6.522B 0.00
Guardant Health (GH) United States $6.447B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.421B 6.31
Halozyme Therapeutics (HALO) United States $6.410B 12.27
TG Therapeutics (TGTX) United States $5.714B 149.96
Nuvalent (NUVL) United States $5.479B 0.00
Telix Pharmaceuticals (TLX) Australia $5.438B 0.00
Axsome Therapeutics (AXSM) United States $5.140B 0.00
Alkermes (ALKS) Ireland $4.718B 12.66
Anbio Biotechnology (NNNN) Germany $4.556B 0.00
ADMA Biologics Inc (ADMA) United States $4.347B 32.52
Akero Therapeutics (AKRO) United States $4.254B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.201B 0.00
Vaxcyte (PCVX) United States $4.194B 0.00
Zealand Pharma (ZLDPF) Denmark $4.070B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.020B 0.00
Krystal Biotech (KRYS) United States $3.972B 30.61
Cytokinetics (CYTK) United States $3.946B 0.00
Zai Lab (ZLAB) China $3.884B 0.00
PTC Therapeutics (PTCT) United States $3.871B 6.74
Merus (MRUS) Netherlands $3.641B 0.00
Arcellx (ACLX) United States $3.629B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.610B 31.72
SpringWorks Therapeutics (SWTX) United States $3.541B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.438B 0.00
Ascentage Pharma Group - (AAPG) China $3.430B 0.00
Protagonist Therapeutics (PTGX) United States $3.426B 73.69
Avidity Biosciences (RNA) United States $3.423B 0.00
Scholar Rock Holding (SRRK) United States $3.363B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.021B 0.00
Metsera (MTSR) United States $2.989B 0.00
Viking Therapeutics (VKTX) United States $2.976B 0.00
Kymera Therapeutics (KYMR) United States $2.842B 0.00
Alvotech (ALVO) Luxembourg $2.750B 15.72
Immunovant (IMVT) United States $2.735B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.624B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.521B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.402B 0.00
ImmunityBio (IBRX) United States $2.330B 0.00
Twist Bioscience (TWST) United States $2.204B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.182B 0.00
Apellis Pharmaceuticals (APLS) United States $2.176B 0.00
Vericel (VCEL) United States $2.142B 1418.33
Bavarian Nordic (BVNRY) Denmark $2.084B 11.01
Recursion Pharmaceuticals (RXRX) United States $2.057B 0.00
Denali Therapeutics (DNLI) United States $2.032B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.019B 0.00
Apogee Therapeutics (APGE) United States $2.000B 0.00
NovoCure (NVCR) Jersey $1.984B 0.00
CG Oncology (CGON) United States $1.982B 0.00
Agios Pharmaceuticals (AGIO) United States $1.926B 0.00
Certara (CERT) United States $1.898B 35.46
GRAIL (GRAL) United States $1.850B 0.00
IDEAYA Biosciences (IDYA) United States $1.841B 0.00
Belite Bio (BLTE) United States $1.837B 0.00
Disc Medicine (IRON) United States $1.834B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.815B 12.06
Adaptive Biotechnologies (ADPT) United States $1.770B 0.00
Amicus Therapeutics (FOLD) United States $1.764B 191.00
Beam Therapeutics (BEAM) United States $1.710B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.702B 0.00
Sarepta Therapeutics (SRPT) United States $1.681B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.671B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.576B 0.00
Vera Therapeutics (VERA) United States $1.503B 0.00
Biohaven (BHVN) United States $1.441B 0.00
89BIO (ETNB) United States $1.434B 0.00
ANI Pharmaceuticals (ANIP) United States $1.413B 14.56
Mesoblast (MESO) Australia $1.392B 0.00
Edgewise Therapeutics (EWTX) United States $1.379B 0.00
Janux Therapeutics (JANX) United States $1.367B 0.00
Celldex Therapeutics (CLDX) United States $1.351B 0.00
Travere Therapeutics (TVTX) United States $1.314B 0.00
CureVac (CVAC) Germany $1.218B 5.90
Dynavax Technologies (DVAX) United States $1.191B 70.86
Structure Therapeutics (GPCR) United States $1.189B 0.00
Viridian Therapeutics (VRDN) United States $1.141B 0.00
MannKind (MNKD) United States $1.137B 23.38
Niagen Bioscience (NAGE) United States $1.135B 160.11
Pacira BioSciences (PCRX) United States $1.106B 10.53
Liquidia Technologies (LQDA) United States $1.065B 0.00
BGM Group (BGM) China $1.030B 0.00
AbCellera Biologics (ABCL) Canada $1.024B 0.00
Novavax (NVAX) United States $1.020B 2.38
WAVE Life Sciences (WVE) Singapore $1.011B 0.00
Intellia Therapeutics (NTLA) United States $0.972B 0.00
NeoGenomics (NEO) United States $0.941B 0.00
Pharvaris (PHVS) Netherlands $0.920B 0.00
MiMedx (MDXG) United States $0.902B 21.82
Spyre Therapeutics (SYRE) United States $0.902B 0.00
Geron (GERN) United States $0.898B 0.00
Mineralys Therapeutics (MLYS) United States $0.882B 0.00
Zymeworks (ZYME) United States $0.873B 0.00
Nurix Therapeutics (NRIX) United States $0.868B 0.00
Oric Pharmaceuticals (ORIC) United States $0.865B 0.00
Arcus Biosciences (RCUS) United States $0.862B 0.00
Praxis Precision Medicines (PRAX) United States $0.857B 0.00
Oculis Holding AG (OCS) Switzerland $0.847B 0.00
CorMedix Inc (CRMD) United States $0.836B 56.00
LENZ Therapeutics (LENZ) United States $0.825B 0.00
Cogent Biosciences (COGT) United States $0.817B 0.00
Immunome (IMNM) United States $0.809B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.806B 0.00
Anavex Life Sciences (AVXL) United States $0.787B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Sionna Therapeutics (SION) United States $0.766B 0.00
UniQure (QURE) Netherlands $0.764B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
ArriVent BioPharma (AVBP) United States $0.745B 0.00
Pharming Group (PHAR) Netherlands $0.727B 0.00
Replimune (REPL) United States $0.716B 0.00
Vir Biotechnology (VIR) United States $0.697B 0.00
Gyre Therapeutics (GYRE) United States $0.689B 183.75
Phathom Pharmaceuticals (PHAT) United States $0.670B 0.00
Nuvation Bio (NUVB) United States $0.664B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.659B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.658B 0.00
Immatics (IMTX) Germany $0.654B 0.00
AnaptysBio (ANAB) United States $0.652B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.648B 0.00
Jyong Biotech (MENS) $0.646B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Trevi Therapeutics (TRVI) United States $0.642B 0.00
GH Research (GHRS) Ireland $0.634B 0.00
Urogen Pharma (URGN) United States $0.632B 0.00
Stoke Therapeutics (STOK) United States $0.620B 14.37
Sana Biotechnology (SANA) United States $0.616B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.607B 0.00
Dianthus Therapeutics (DNTH) United States $0.599B 0.00
Cidara Therapeutics (CDTX) United States $0.595B 0.00
Arbutus Biopharma (ABUS) United States $0.592B 0.00
Upstream Bio (UPB) United States $0.591B 0.00
Castle Biosciences (CSTL) United States $0.590B 40.04
Iovance Biotherapeutics (IOVA) United States $0.574B 0.00
Sage Therapeutics (SAGE) United States $0.571B 0.00
Tango Therapeutics (TNGX) United States $0.555B 0.00
Keros Therapeutics (KROS) United States $0.542B 0.00
Maze Therapeutics (MAZE) United States $0.537B 0.00
Arvinas (ARVN) United States $0.537B 0.00
Opthea (OPT) Australia $0.525B 0.00
MeiraGTx Holdings (MGTX) United States $0.524B 0.00
Tyra Biosciences (TYRA) United States $0.508B 0.00
Bicara Therapeutics (BCAX) United States $0.507B 0.00
Celcuity (CELC) United States $0.506B 0.00
Kura Oncology (KURA) United States $0.500B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.490B 0.00
Myriad Genetics (MYGN) United States $0.489B 0.00
Abivax SA (ABVX) France $0.485B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.481B 0.00
Septerna (SEPN) United States $0.471B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.453B 0.00
ATyr Pharma (ATYR) United States $0.451B 0.00
Fortrea Holdings (FTRE) United States $0.447B 12.35
Kamada (KMDA) Israel $0.446B 26.72
Cullinan Therapeutics (CGEM) United States $0.444B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.431B 0.00
Cytek Biosciences (CTKB) United States $0.431B 0.00
Precigen (PGEN) United States $0.419B 0.00
Rapport Therapeutics (RAPP) United States $0.415B 0.00
PureTech Health (PRTC) United States $0.414B 0.00
REGENXBIO (RGNX) United States $0.412B 0.00
Zenas BioPharma (ZBIO) United States $0.405B 0.00
Eton Pharmaceuticals (ETON) United States $0.382B 0.00
ITeos Therapeutics (ITOS) United States $0.382B 0.00
Rezolute (RZLT) United States $0.381B 0.00
MBX Biosciences (MBX) United States $0.381B 0.00
Solid Biosciences (SLDB) United States $0.378B 0.00
Fulcrum Therapeutics (FULC) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.371B 0.00
Tectonic Therapeutic (TECX) United States $0.371B 0.00
Erasca (ERAS) United States $0.360B 0.00
Compass Therapeutics (CMPX) United States $0.360B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.353B 0.00
Northwest Biotherapeutics (NWBO) United States $0.349B 0.00
Emergent Biosolutions (EBS) United States $0.346B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.342B 0.00
Amarin (AMRN) Ireland $0.336B 0.00
Absci (ABSI) United States $0.328B 0.00
Prothena (PRTA) Ireland $0.327B 0.00
Terns Pharmaceuticals (TERN) United States $0.326B 0.00
Prime Medicine (PRME) United States $0.324B 0.00
Humacyte (HUMA) United States $0.324B 0.00
Crescent Biopharma (CBIO) United States $0.316B 0.00
Aura Biosciences (AURA) United States $0.315B 0.00
Citius Oncology (CTOR) United States $0.311B 0.00
Atea Pharmaceuticals (AVIR) United States $0.308B 0.00
Benitec Biopharma (BNTC) United States $0.307B 0.00
Inventiva S.A (IVA) France $0.305B 0.00
Astria Therapeutics (ATXS) United States $0.302B 0.00
XOMA Royalty (XOMA) United States $0.302B 0.00
Lifecore Biomedical (LFCR) United States $0.301B 0.00
Aardvark Therapeutics (AARD) United States $0.293B 0.00
Olema Pharmaceuticals (OLMA) United States $0.291B 0.00
Abeona Therapeutics (ABEO) United States $0.291B 0.00
Ocugen (OCGN) United States $0.283B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.282B 0.00
Gossamer Bio (GOSS) United States $0.280B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.278B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.277B 56.38
Corvus Pharmaceuticals (CRVS) United States $0.273B 0.00
Cartesian Therapeutics (RNAC) United States $0.270B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.266B 0.00
Annexon (ANNX) United States $0.263B 0.00
Alpha Teknova (TKNO) United States $0.262B 0.00
Foghorn Therapeutics (FHTX) United States $0.262B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.262B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
Entrada Therapeutics (TRDA) United States $0.255B 8.30
Candel Therapeutics (CADL) United States $0.254B 0.00
DBV Technologies S.A (DBVT) France $0.251B 0.00
Palvella Therapeutics (PVLA) United States $0.249B 0.00
Allogene Therapeutics (ALLO) United States $0.247B 0.00
Third Harmonic Bio (THRD) United States $0.245B 0.00
Prima BioMed (IMMP) Australia $0.240B 0.00
Sagimet Biosciences (SGMT) United States $0.234B 0.00
MaxCyte (MXCT) United States $0.232B 0.00
Semper Paratus Acquisition (TVGN) United States $0.230B 0.00
Adherex Technologies (FENC) United States $0.229B 0.00
Verastem (VSTM) United States $0.228B 0.00
Monopar Therapeutics (MNPR) United States $0.219B 0.00
SELLAS Life Sciences (SLS) United States $0.219B 0.00
Tvardi Therapeutics (TVRD) United States $0.218B 0.00
Adocia (ADOCY) France $0.216B 0.00
BioStem Technologies (BSEM) $0.215B 8.74
ProQR Therapeutics (PRQR) Netherlands $0.215B 0.00
Neurogene (NGNE) United States $0.213B 0.00
Cardiff Oncology (CRDF) United States $0.210B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.207B 0.00
Inhibrx Biosciences (INBX) United States $0.207B 0.12
Y-mAbs Therapeutics (YMAB) United States $0.204B 0.00
AC Immune (ACIU) Switzerland $0.204B 0.00
Vor Biopharma (VOR) $0.202B 0.00
Codexis (CDXS) United States $0.202B 0.00
ScPharmaceuticals (SCPH) United States $0.201B 0.00
I-Mab (IMAB) United States $0.198B 0.00
Kodiak Sciences (KOD) United States $0.197B 0.00
Design Therapeutics (DSGN) United States $0.191B 0.00
CARGO Therapeutics (CRGX) United States $0.190B 0.00
GENFIT S.A (GNFT) France $0.186B 0.00
EnGene Holdings (ENGN) Canada $0.186B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.185B 0.00
Editas Medicine (EDIT) United States $0.184B 0.00
Bright Minds Biosciences (DRUG) United States $0.184B 0.00
CytomX Therapeutics (CTMX) United States $0.183B 4.73
Voyager Therapeutics (VYGR) United States $0.172B 0.00
Puma Biotechnology (PBYI) United States $0.170B 4.45
Innate Pharma S.A (IPHA) France $0.167B 0.00
DiaMedica Therapeutics (DMAC) United States $0.167B 0.00
Alumis (ALMS) United States $0.163B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.162B 0.00
Spero Therapeutics (SPRO) United States $0.162B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.162B 0.00
Compugen (CGEN) Israel $0.159B 0.00
Nuvectis Pharma (NVCT) United States $0.156B 0.00
Molecular Partners AG (MOLN) Switzerland $0.154B 0.00
Ventyx Biosciences (VTYX) United States $0.152B 0.00
Anika Therapeutics (ANIK) United States $0.152B 0.00
Alpha Cognition (ACOG) Canada $0.149B 0.00
BioAge Labs (BIOA) United States $0.148B 0.00
Black Diamond Therapeutics (BDTX) United States $0.141B 41.33
Alector (ALEC) United States $0.140B 0.00
Instil Bio (TIL) United States $0.137B 0.00
23andMe Holding (MEHCQ) United States $0.137B 0.00
Kyverna Therapeutics (KYTX) United States $0.133B 0.00
Rapt Therapeutics (RAPT) United States $0.132B 0.00
Skye Bioscience (SKYE) United States $0.129B 0.00
Fate Therapeutics (FATE) United States $0.128B 0.00
Sangamo Therapeutics (SGMO) United States $0.126B 0.00
Seer (SEER) United States $0.126B 0.00
Agenus (AGEN) United States $0.125B 0.00
Elicio Therapeutics (ELTX) United States $0.124B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.123B 0.00
Immuneering (IMRX) United States $0.121B 0.00
Greenwich LifeSciences (GLSI) United States $0.121B 0.00
Actuate Therapeutics (ACTU) United States $0.120B 0.00
Neumora Therapeutics (NMRA) United States $0.119B 0.00
Nkarta (NKTX) United States $0.118B 0.00
Caribou Biosciences (CRBU) United States $0.117B 0.00
BioHarvest Sciences (BHST) Canada $0.111B 0.00
Theratechnologies (THTX) Canada $0.109B 0.00
Genelux (GNLX) United States $0.108B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.106B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.104B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.104B 0.00
Contineum Therapeutics (CTNM) United States $0.103B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.103B 0.00
C4 Therapeutics (CCCC) United States $0.102B 0.00
HilleVax (HLVX) United States $0.100B 0.00
Tenaya Therapeutics (TNYA) United States $0.099B 0.00
TuHURA Biosciences (HURA) United States $0.097B 0.00
Seres Therapeutics (MCRB) United States $0.097B 0.00
Coya Therapeutics (COYA) United States $0.096B 0.00
BeyondSpring (BYSI) United States $0.095B 0.00
Adagene (ADAG) China $0.092B 0.00
IO Biotech (IOBT) Denmark $0.092B 0.00
Nautilus Biotechnology (NAUT) United States $0.091B 0.00
XBiotech (XBIT) United States $0.091B 0.00
Whitehawk Therapeutics (WHWK) United States $0.088B 0.00
OKYO Pharma (OKYO) $0.087B 0.00
Entera Bio (ENTX) Israel $0.086B 0.00
Invivyd (IVVD) United States $0.086B 0.00
Forte Biosciences (FBRX) United States $0.085B 0.00
Coherus Oncology (CHRS) United States $0.085B 0.00
Cellectis S.A (CLLS) France $0.085B 0.00
Climb Bio (CLYM) United States $0.084B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.083B 0.00
Jasper Therapeutics (JSPR) United States $0.083B 0.00
EXoZymes (EXOZ) United States $0.083B 0.00
TScan Therapeutics (TCRX) United States $0.082B 0.00
Elutia (ELUT) United States $0.081B 0.00
Cabaletta Bio (CABA) United States $0.077B 0.00
TELA Bio (TELA) United States $0.077B 0.00
Quince Therapeutics (QNCX) United States $0.075B 0.00
Inovio Pharmaceuticals (INO) United States $0.075B 0.00
Oncolytics Biotech (ONCY) Canada $0.073B 0.00
Zura Bio (ZURA) United States $0.072B 0.00
Pliant Therapeutics (PLRX) United States $0.071B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.070B 0.00
Biomea Fusion (BMEA) United States $0.068B 0.00
IGM Biosciences (IGMS) United States $0.067B 0.00
Immunic (IMUX) United States $0.067B 0.00
Akoya Biosciences (AKYA) United States $0.065B 0.00
Ikena Oncology (IKNA) United States $0.065B 0.00
MediciNova (MNOV) United States $0.064B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.064B 0.00
Clearside Biomedical (CLSD) United States $0.062B 0.00
PDS Biotechnology (PDSB) United States $0.061B 0.00
Sutro Biopharma (STRO) United States $0.060B 0.00
Repare Therapeutics (RPTX) Canada $0.060B 0.00
Alto Neuroscience (ANRO) United States $0.060B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.059B 0.00
Quantum Biopharma (QNTM) Canada $0.059B 0.00
VistaGen Therapeutics (VTGN) United States $0.058B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
ZIVO Bioscience (ZIVO) United States $0.057B 0.00
Opus Genetics (IRD) United States $0.056B 0.00
Earth Science Tech (ETST) United States $0.056B 0.00
Genenta Science S.p.A (GNTA) Italy $0.056B 0.00
Senti Biosciences (SNTI) United States $0.055B 0.00
Fortress Biotech (FBIO) United States $0.055B 0.00
CervoMed (CRVO) United States $0.055B 0.00
Connect Biopharma Holdings (CNTB) United States $0.054B 0.00
Adlai Nortye (ANL) Cayman Islands $0.054B 0.00
Oncobiologics (OTLK) United States $0.054B 0.00
INmune Bio (INMB) United States $0.053B 0.00
InflaRx (IFRX) Germany $0.053B 0.00
Cue Biopharma (CUE) United States $0.051B 0.00
Adicet Bio (ACET) United States $0.050B 0.00
Kalaris Therapeutics (KLRS) United States $0.050B 0.00
Renovaro (RENB) United States $0.050B 0.00
Werewolf Therapeutics (HOWL) United States $0.049B 0.00
RenovoRx (RNXT) United States $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Celularity (CELU) United States $0.047B 0.00
Precision BioSciences (DTIL) United States $0.047B 0.00
Atara Biotherapeutics (ATRA) United States $0.046B 0.00
Adverum Biotechnologies (ADVM) United States $0.045B 0.00
Exicure (XCUR) United States $0.044B 0.00
Aligos Therapeutics (ALGS) United States $0.044B 0.00
Applied Therapeutics (APLT) United States $0.044B 0.00
Annovis Bio (ANVS) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Scilex Holding (SCLX) United States $0.041B 0.00
Medicus Pharma (MDCX) United States $0.041B 0.00
Pluri (PLUR) Israel $0.039B 0.00
Shattuck Labs (STTK) United States $0.038B 0.00
ABVC BioPharma (ABVC) United States $0.038B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.038B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.038B 0.00
Mersana Therapeutics (MRSN) United States $0.037B 0.00
Artiva Biotherapeutics (ARTV) United States $0.037B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
PepGen (PEPG) United States $0.036B 0.00
Alterity Therapeutics - (ATHE) Australia $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Clene (CLNN) United States $0.035B 0.00
Estrella Immunopharma (ESLA) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
OnKure Therapeutics (OKUR) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
Rein Therapeutics (RNTX) United States $0.031B 0.00
KALA BIO (KALA) United States $0.031B 0.00
Eyenovia (EYEN) United States $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Rani Therapeutics Holdings (RANI) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
CAMP4 Therapeutics (CAMP) United States $0.029B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.027B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.026B 0.00
Lisata Therapeutics (LSTA) United States $0.025B 0.00
Passage Bio (PASG) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
Curis (CRIS) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
FibroBiologics (FBLG) United States $0.024B 0.00
Cadrenal Therapeutics (CVKD) United States $0.024B 0.00
Ovid Therapeutics (OVID) United States $0.023B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Boundless Bio (BOLD) United States $0.023B 0.00
CalciMedica (CALC) United States $0.022B 0.00
ALX Oncology Holdings (ALXO) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
Generation Bio (GBIO) United States $0.021B 0.00
Dare Bioscience (DARE) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
BRIACELL THERAP (BCTX) Canada $0.020B 0.00
Aytu BioPharma (AYTU) United States $0.020B 0.00
Longeveron (LGVN) United States $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
Q32 Bio (QTTB) United States $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.017B 0.00
Cingulate (CING) United States $0.017B 0.00
Gelteq (GELS) Australia $0.016B 0.00
SAB Biotherapeutics (SABS) United States $0.016B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
Advanced Biomed (ADVB) United States $0.015B 0.00
Beyond Air (XAIR) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
Equillium (EQ) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.011B 0.00
X4 Pharmaceuticals (XFOR) United States $0.011B 0.00
BioXcel Therapeutics (BTAI) United States $0.011B 0.00
Synaptogenix (SNPX) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
GT Biopharma (GTBP) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Artelo Biosciences (ARTL) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
UNITY Biotechnology (UBX) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
GENPREX (GNPX) United States $0.006B 0.00
IN8bio (INAB) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Moleculin Biotech (MBRX) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00